Cardiovascular Diabetology

1. Cardiovasc Diabetol17 Aug 2023

   Association between cumulative atherogenic index of plasma exposure and risk of myocardial infarction in the general population

   Cohort study

2. Cardiovasc Diabetol17 Aug 2023

   Early vascular aging as an index of cardiovascular risk in healthy adults: confirmatory factor analysis from the EVasCu study

   Cross-sectional study

3. Cardiovasc Diabetol11 Aug 2023

   Empagliflozin improves insulin sensitivity in patients with recent acute coronary syndrome and newly detected dysglycaemia : Experiences from the randomized, controlled SOCOGAMI trial

   Randomized controlled trialT2D & other

4. Cardiovasc Diabetol10 Aug 2023

   Causal associations of remnant cholesterol with cardiometabolic diseases and risk factors: a mendelian randomization analysis

   Research article

5. Cardiovasc Diabetol10 Aug 2023

   Nonlinear relationship between atherogenic index of plasma and the risk of prediabetes: a retrospective study based on Chinese adults

   Cohort studyT2D & other

6. Cardiovasc Diabetol10 Aug 2023

   Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus

   Cross-sectional studyT1D

7. Cardiovasc Diabetol10 Aug 2023

   Elevated urine albumin creatinine ratio increases cardiovascular mortality in coronary artery disease patients with or without type 2 diabetes mellitus: a multicenter retrospective study

   Cohort studyT2D & other

8. Cardiovasc Diabetol10 Aug 2023

   Correlation analysis of the abdominal visceral fat area with the structure and function of the heart and liver in obesity: a prospective magnetic resonance imaging study

   Cross-sectional studyObesity

9. Cardiovasc Diabetol4 Aug 2023

   Prognostic importance of glycemic variability on left ventricular reverse remodeling after the first episode of ST-segment elevation myocardial infarction

   Cohort study

10. Cardiovasc Diabetol4 Aug 2023

    An innovative model for predicting coronary heart disease using triglyceride-glucose index: a machine learning-based cohort study

    Cohort studyT2D & other

11. Cardiovasc Diabetol3 Aug 2023

    Plasma lipidic fingerprint associated with type 2 diabetes in patients with coronary heart disease: CORDIOPREV study

    Cohort studyT2D & other

12. Cardiovasc Diabetol3 Aug 2023

    Prognostic value of triglyceride glucose index in population at high cardiovascular disease risk

    Cohort study

13. Cardiovasc Diabetol31 Jul 2023

    Rationale and design of an investigator-initiated, multicenter, prospective, placebo-controlled, double-blind, randomized trial to evaluate the effects of finerenone on vascular stiffness and cardiorenal biomarkers in type 2 diabetes and chronic kidney disease (FIVE-STAR)

    Trial designT2D & other

14. Cardiovasc Diabetol29 Jul 2023

    Smoking behavior change and risk of cardiovascular disease incidence and mortality in patients with type 2 diabetes mellitus

    Cohort studyT2D & other

15. Cardiovasc Diabetol28 Jul 2023

    Association of sodium-glucose cotransporter 2 inhibitors with post-discharge outcomes in patients with acute heart failure with type 2 diabetes: a cohort study

    Cohort studyT2D & other

16. Cardiovasc Diabetol27 Jul 2023

    Triglyceride-glucose index is associated with the occurrence and prognosis of cardiac arrest: a multicenter retrospective observational study

    Cohort study

17. Cardiovasc Diabetol26 Jul 2023

    Comparative cardiovascular outcomes in type 2 diabetes patients taking dapagliflozin versus empagliflozin: a nationwide population-based cohort study

    Cohort studyT2D & other

18. Cardiovasc Diabetol26 Jul 2023

    Global trans-lesional computed tomography-derived fractional flow reserve gradient is associated with clinical outcomes in diabetic patients with non-obstructive coronary artery disease

    Cohort studyT2D & other

19. Cardiovasc Diabetol26 Jul 2023

    Triglycerides and risk of cardiovascular events in statin-treated patients with newly diagnosed type 2 diabetes: a Danish cohort study

    Cohort studyT2D & other

20. Cardiovasc Diabetol26 Jul 2023

    The impact of the stress hyperglycemia ratio on mortality and rehospitalization rate in patients with acute decompensated heart failure and diabetes

    Cohort studyT2D & other

21. Cardiovasc Diabetol22 Jul 2023

    Comparison of SGLT2 inhibitors with DPP-4 inhibitors combined with metformin in patients with acute myocardial infarction and diabetes mellitus

    Cohort studyT2D & other

22. Cardiovasc Diabetol20 Jul 2023

    Alterations in trimethylamine-N-oxide in response to Empagliflozin therapy: a secondary analysis of the EMMY trial

    Secondary analysisT2D & other

23. Cardiovasc Diabetol20 Jul 2023

    Association of variability in metabolic parameters with the incidence of type 2 diabetes: evidence from a functional community cohort

    Cohort studyT2D & other

24. Cardiovasc Diabetol17 Jul 2023

    Elevated plasma factor XI predicts cardiovascular events in patients with type 2 diabetes: a long-term observational study

    Cohort studyT2D & other

25. Cardiovasc Diabetol15 Jul 2023

    Supra-additive effect of chronic inflammation and atherogenic dyslipidemia on developing type 2 diabetes among young adults: a prospective cohort study

    Cohort studyT2D & other

26. Cardiovasc Diabetol15 Jul 2023

    High triglyceride-glucose index and stress hyperglycemia ratio as predictors of adverse cardiac events in patients with coronary chronic total occlusion: a large-scale prospective cohort study

    Cohort study

27. Cardiovasc Diabetol14 Jul 2023

    Epidemiology of the first-ever cardiovascular event in people with type 1 diabetes: a retrospective cohort population-based study in Catalonia

    Cohort studyT1D

28. Cardiovasc Diabetol13 Jul 2023

    Impact of diabetes mellitus on disease severity and patient survival in idiopathic pulmonary arterial hypertension: data from the Polish multicentre registry (BNP-PL)

    Cohort studyT2D & other

29. Cardiovasc Diabetol13 Jul 2023

    Left atrioventricular interaction and impaired left atrial phasic function in type 2 diabetes mellitus patients with or without anemia: a cardiac magnetic resonance study

    Cross-sectional studyT2D & other

30. Cardiovasc Diabetol12 Jul 2023

    Insulin growth factor axis and cardio-renal risk in diabetic kidney disease: an analysis from the CREDENCE trial

    Secondary analysisT2D & other

31. Cardiovasc Diabetol12 Jul 2023

    Impact of glycated hemoglobin on 2-year clinical outcomes in elderly patients with atrial fibrillation: sub-analysis of ANAFIE Registry, a large observational study

    Secondary analysisT2D & other

32. Cardiovasc Diabetol12 Jul 2023

    Glyoxal in hyperglycaemic ischemic stroke – a cohort study

    Cohort study

33. Cardiovasc Diabetol7 Jul 2023

    Association between the triglyceride–glucose index and the risk of mortality among patients with chronic heart failure: results from a retrospective cohort study in China

    Cohort study

34. Cardiovasc Diabetol6 Jul 2023

    Triglyceride-glucose index and coronary artery disease: a systematic review and meta-analysis of risk, severity, and prognosis

    Meta-analysis

35. Cardiovasc Diabetol6 Jul 2023

    Both LDL and HDL particle concentrations associate positively with an increased risk of developing microvascular complications in patients with type 2 diabetes: lost protection by HDL (Zodiac-63)

    Cohort studyT2D & other

36. Cardiovasc Diabetol6 Jul 2023

    Visit-to-visit HbA1c variability is associated with aortic stiffness progression in participants with type 2 diabetes

    Cohort studyT2D & other

37. Cardiovasc Diabetol5 Jul 2023

    Impact of the SGLT2-inhibitor empagliflozin on inflammatory biomarkers after acute myocardial infarction – a post-hoc analysis of the EMMY trial

    Secondary analysisT2D & other

38. Cardiovasc Diabetol4 Jul 2023

    The impact of fasting stress hyperglycemia ratio, fasting plasma glucose and hemoglobin A1c on in-hospital mortality in patients with and without diabetes: findings from the China acute myocardial infarction registry

    Cohort studyT2D & other

39. Cardiovasc Diabetol30 Jun 2023

    Effect of onset of type 2 diabetes on risks of cardiovascular disease and heart failure among new Zealanders with impaired glucose tolerance over 25 years: tapered-matched landmark analysis

    Cohort studyT2D & other

40. Cardiovasc Diabetol29 Jun 2023

    Association between non-insulin-based insulin resistance indices and cardiovascular events in patients undergoing percutaneous coronary intervention: a retrospective study

    Cohort study

All 1,291 Briefs in ExploreShowing Briefs 1,121–1,160 of 1,291, newest first